<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39201692</PMID><DateCompleted><Year>2024</Year><Month>08</Month><Day>29</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>03</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>25</Volume><Issue>16</Issue><PubDate><Year>2024</Year><Month>Aug</Month><Day>19</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>STAT3 Increases CVB3 Replication and Acute Pancreatitis and Myocarditis Pathology via Impeding Nuclear Translocation of STAT1 and Interferon-Stimulated Gene Expression.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">9007</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms25169007</ELocationID><Abstract><AbstractText>Acute pancreatitis (AP) is an inflammatory disease initiated by the death of exocrine acinar cells, but its pathogenesis remains unclear. Signal transducer and activator of transcription 3 (STAT3) is a multifunctional factor that regulates immunity and the inflammatory response. The protective role of STAT3 is reported in Coxsackievirus B3 (CVB3)-induced cardiac fibrosis, yet the exact role of STAT3 in modulating viral-induced STAT1 activation and type I interferon (IFN)-stimulated gene (ISG) transcription in the pancreas remains unclarified. In this study, we tested whether STAT3 regulated viral-induced STAT1 translocation. We found that CVB3, particularly capsid VP1 protein, markedly upregulated the phosphorylation and nuclear import of STAT3 (p-STAT3) while it significantly impeded the nuclear translocation of p-STAT1 in the pancreases and hearts of mice on day 3 postinfection (p.i.). Immunoblotting and an immunofluorescent assay demonstrated the increased expression and nuclear translocation of p-STAT3 but a blunted p-STAT1 nuclear translocation in CVB3-infected acinar 266-6 cells. STAT3 shRNA knockdown or STAT3 inhibitors reduced viral replication via the rescue of STAT1 nuclear translocation and increasing the ISRE activity and ISG transcription in vitro. The knockdown of STAT1 blocked the antiviral effect of the STAT3 inhibitor. STAT3 inhibits STAT1 activation by virally inducing a potent inhibitor of IFN signaling, the suppressor of cytokine signaling-3 ((SOCS)-3). Sustained pSTAT1 and the elevated expression of ISGs were induced in SOCS3 knockdown cells. The in vivo administration of HJC0152, a pharmaceutical STAT3 inhibitor, mitigated the viral-induced AP and myocarditis pathology via increasing the IFNβ as well as ISG expression on day 3 p.i. and reducing the viral load in multi-organs. These findings define STAT3 as a negative regulator of the type I IFN response via impeding the nuclear STAT1 translocation that otherwise triggers ISG induction in infected pancreases and hearts. Our findings identify STAT3 as an antagonizing factor of the IFN-STAT1 signaling pathway and provide a potential therapeutic target for viral-induced AP and myocarditis.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Liang</LastName><ForeName>Tianming</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Jiangsu Provincial Key Laboratory of Infection and Immunity, Institutes of Biology and Medical Sciences, Soochow University, Suzhou 215123, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Zhipeng</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Jiangsu Provincial Key Laboratory of Infection and Immunity, Institutes of Biology and Medical Sciences, Soochow University, Suzhou 215123, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bai</LastName><ForeName>Zhenxin</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Jiangsu Provincial Key Laboratory of Infection and Immunity, Institutes of Biology and Medical Sciences, Soochow University, Suzhou 215123, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Le</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Jiangsu Provincial Key Laboratory of Infection and Immunity, Institutes of Biology and Medical Sciences, Soochow University, Suzhou 215123, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Wei</ForeName><Initials>W</Initials><Identifier Source="ORCID">0000-0003-2652-8244</Identifier><AffiliationInfo><Affiliation>Jiangsu Provincial Key Laboratory of Infection and Immunity, Institutes of Biology and Medical Sciences, Soochow University, Suzhou 215123, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>82171807, 31870903</GrantID><Agency>NSFC</Agency><Country /></Grant><Grant><GrantID>22KJA310005</GrantID><Agency>Major Project of Natural Science Research in Jiangsu Higher Education Institutions</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>08</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D050794">STAT1 Transcription Factor</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D050796">STAT3 Transcription Factor</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C494080">Stat1 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C494087">Stat3 protein, mouse</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D050794" MajorTopicYN="Y">STAT1 Transcription Factor</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009205" MajorTopicYN="Y">Myocarditis</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D050796" MajorTopicYN="Y">STAT3 Transcription Factor</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010195" MajorTopicYN="Y">Pancreatitis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D029822" MajorTopicYN="Y">Enterovirus B, Human</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014779" MajorTopicYN="Y">Virus Replication</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003384" MajorTopicYN="N">Coxsackievirus Infections</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002467" MajorTopicYN="N">Cell Nucleus</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D021581" MajorTopicYN="N">Active Transport, Cell Nucleus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005786" MajorTopicYN="N">Gene Expression Regulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000208" MajorTopicYN="N">Acute Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CVB3</Keyword><Keyword MajorTopicYN="N">ISG</Keyword><Keyword MajorTopicYN="N">STAT1</Keyword><Keyword MajorTopicYN="N">STAT3</Keyword><Keyword MajorTopicYN="N">acute pancreatitis</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as potential conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>7</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>8</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>1</Day><Hour>16</Hour><Minute>17</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>8</Month><Day>31</Day><Hour>9</Hour><Minute>49</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>8</Month><Day>29</Day><Hour>1</Hour><Minute>14</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>8</Month><Day>19</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39201692</ArticleId><ArticleId IdType="pmc">PMC11354559</ArticleId><ArticleId IdType="doi">10.3390/ijms25169007</ArticleId><ArticleId IdType="pii">ijms25169007</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Boxhoorn L., Voermans R.P., Bouwense S.A., Bruno M.J., Verdonk R.C., Boermeester M.A., Van Santvoort H.C., Besselink M.G. Acute pancreatitis. Lancet. 2020;396:726–734. doi: 10.1016/S0140-6736(20)31310-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)31310-6</ArticleId><ArticleId IdType="pubmed">32891214</ArticleId></ArticleIdList></Reference><Reference><Citation>Habtezion A. Inflammation in acute and chronic pancreatitis. Curr. Opin. Gastroenterol. 2015;31:395–399. doi: 10.1097/MOG.0000000000000195.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MOG.0000000000000195</ArticleId><ArticleId IdType="pmc">PMC4618697</ArticleId><ArticleId IdType="pubmed">26107390</ArticleId></ArticleIdList></Reference><Reference><Citation>Huber S., Ramsingh A.I. Coxsackievirus-induced pancreatitis. Viral Immunol. 2004;17:358–369. doi: 10.1089/vim.2004.17.358.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/vim.2004.17.358</ArticleId><ArticleId IdType="pubmed">15357902</ArticleId></ArticleIdList></Reference><Reference><Citation>Szatmary P., Grammatikopoulos T., Cai W., Huang W., Mukherjee R., Halloran C., Beyer G., Sutton R. Acute Pancreatitis: Diagnosis and Treatment. Drugs. 2022;82:1251–1276. doi: 10.1007/s40265-022-01766-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40265-022-01766-4</ArticleId><ArticleId IdType="pmc">PMC9454414</ArticleId><ArticleId IdType="pubmed">36074322</ArticleId></ArticleIdList></Reference><Reference><Citation>McNab F., Mayer-Barber K., Sher A., Wack A., O’Garra A. Type I interferons in infectious disease. Nat. Rev. Immunol. 2015;15:87–103. doi: 10.1038/nri3787.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri3787</ArticleId><ArticleId IdType="pmc">PMC7162685</ArticleId><ArticleId IdType="pubmed">25614319</ArticleId></ArticleIdList></Reference><Reference><Citation>Darnell J.E., Jr., Kerr I.M., Stark G.R. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science. 1994;264:1415–1421. doi: 10.1126/science.8197455.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.8197455</ArticleId><ArticleId IdType="pubmed">8197455</ArticleId></ArticleIdList></Reference><Reference><Citation>Schoggins J.W. Recent advances in antiviral interferon-stimulated gene biology. F1000Research. 2018;7:309. doi: 10.12688/f1000research.12450.1.</Citation><ArticleIdList><ArticleId IdType="doi">10.12688/f1000research.12450.1</ArticleId><ArticleId IdType="pmc">PMC5850085</ArticleId><ArticleId IdType="pubmed">29568506</ArticleId></ArticleIdList></Reference><Reference><Citation>Haller O., Staeheli P., Schwemmle M., Kochs G. Mx GTPases: Dynamin-like antiviral machines of innate immunity. Trends Microbiol. 2015;23:154–163. doi: 10.1016/j.tim.2014.12.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tim.2014.12.003</ArticleId><ArticleId IdType="pubmed">25572883</ArticleId></ArticleIdList></Reference><Reference><Citation>Shiratori T., Imaizumi T., Hirono K., Kawaguchi S., Matsumiya T., Seya K., Tasaka S. ISG56 is involved in CXCL10 expression induced by TLR3 signaling in BEAS-2B bronchial epithelial cells. Exp. Lung. Res. 2020;46:195–202. doi: 10.1080/01902148.2020.1760965.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/01902148.2020.1760965</ArticleId><ArticleId IdType="pubmed">32363951</ArticleId></ArticleIdList></Reference><Reference><Citation>Dzimianski J.V., Scholte F.E.M., Bergeron É., Pegan S.D. ISG15: It’s Complicated. J. Mol. Biol. 2019;431:4203–4216. doi: 10.1016/j.jmb.2019.03.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmb.2019.03.013</ArticleId><ArticleId IdType="pmc">PMC6746611</ArticleId><ArticleId IdType="pubmed">30890331</ArticleId></ArticleIdList></Reference><Reference><Citation>Panayiotou C., Lindqvist R., Kurhade C., Vonderstein K., Pasto J., Edlund K., Upadhyay A.S., Överby A.K. Viperin Restricts Zika Virus and Tick-Borne Encephalitis Virus Replication by Targeting NS3 for Proteasomal Degradation. J. Virol. 2018;92:e02054-17. doi: 10.1128/JVI.02054-17.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02054-17</ArticleId><ArticleId IdType="pmc">PMC5972904</ArticleId><ArticleId IdType="pubmed">29321318</ArticleId></ArticleIdList></Reference><Reference><Citation>Grabowski F., Kochańczyk M., Korwek Z., Czerkies M., Prus W., Lipniacki T. Antagonism between viral infection and innate immunity at the single-cell level. PLoS Pathog. 2023;19:e1011597. doi: 10.1371/journal.ppat.1011597.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1011597</ArticleId><ArticleId IdType="pmc">PMC10503725</ArticleId><ArticleId IdType="pubmed">37669278</ArticleId></ArticleIdList></Reference><Reference><Citation>Xia H., Cao Z., Xie X., Zhang X., Chen J.Y., Wang H., Menachery V.D., Rajsbaum R., Shi P.Y. Evasion of Type I Interferon by SARS-CoV-2. Evasion of Type I Interferon by SARS-CoV-2. Cell Rep. 2020;33:108234. doi: 10.1016/j.celrep.2020.108234.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2020.108234</ArticleId><ArticleId IdType="pmc">PMC7501843</ArticleId><ArticleId IdType="pubmed">32979938</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalinke U. Interferon-beta expression and type I interferon receptor signaling of hepatocytes prevent hepatic necrosis and virus dissemination in Coxsackievirus B3-infected mice. PLoS Pathog. 2018;14:e1007235.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6107283</ArticleId><ArticleId IdType="pubmed">30075026</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu H., Li M., Song Y., Xu W. TRIM21 Restricts Coxsackievirus B3 Replication, Cardiac and Pancreatic Injury via Interacting With MAVS and Positively Regulating IRF3-Mediated Type-I Interferon Production. Front. Immunol. 2018;9:2479. doi: 10.3389/fimmu.2018.02479.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.02479</ArticleId><ArticleId IdType="pmc">PMC6209670</ArticleId><ArticleId IdType="pubmed">30410495</ArticleId></ArticleIdList></Reference><Reference><Citation>Schultheiss H.P., Rauch U. Protease-activated receptor-2 regulates the innate immune response to viral infection in a coxsackievirus B3-induced myocarditis. J. Am. Coll. Cardiol. 2013;62:1737–1745.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4077621</ArticleId><ArticleId IdType="pubmed">23871888</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng Q., Langereis M.A., Lork M., Nguyen M., Hato S.V., Lanke K., Mdad L., Bhoopathi P., Fisher P.B., Lloyd R.E., et al. Enterovirus 2Apro targets MDA5 and MAVS in infected cells. J. Virol. 2014;88:3369–3378. doi: 10.1128/JVI.02712-13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02712-13</ArticleId><ArticleId IdType="pmc">PMC3957915</ArticleId><ArticleId IdType="pubmed">24390337</ArticleId></ArticleIdList></Reference><Reference><Citation>Visser L.J., Langereis M.A., Rabouw H.H., Wahedi M., Muntjewerff E.M., De Groot R.J., Van Kuppeveld F.J.M. Essential Role of Enterovirus 2A Protease in Counteracting Stress Granule Formation and the Induction of Type I Interferon. J. Virol. 2019;93:e00222-19. doi: 10.1128/JVI.00222-19.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00222-19</ArticleId><ArticleId IdType="pmc">PMC6498061</ArticleId><ArticleId IdType="pubmed">30867299</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruppert V., Meyer T., Pankuweit S., Jonsdottir T., Maisch B. Activation of STAT1 transcription factor precedes up-regulation of coxsackievirus-adenovirus receptor during viral myocarditis. Cardiovasc. Pathol. 2008;17:81–92. doi: 10.1016/j.carpath.2007.07.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.carpath.2007.07.004</ArticleId><ArticleId IdType="pubmed">18329552</ArticleId></ArticleIdList></Reference><Reference><Citation>Antoniak S., Owens A.P., Baunacke M., Williams J.C., Lee R.D., Weithäuser A., Sheridan P.A., Malz R., Luyendyk J.P., Esserman D.A., et al. PAR-1 contributes to the innate immune response during viral infection. J. Clin. Investig. 2013;123:1310–1322. doi: 10.1172/JCI66125.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI66125</ArticleId><ArticleId IdType="pmc">PMC3582138</ArticleId><ArticleId IdType="pubmed">23391721</ArticleId></ArticleIdList></Reference><Reference><Citation>Butturini E., Carcereri De Prati A., Mariotto S. Redox Regulation of STAT1 and STAT3 Signaling. Int. J. Mol. Sci. 2020;21:7034. doi: 10.3390/ijms21197034.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21197034</ArticleId><ArticleId IdType="pmc">PMC7582491</ArticleId><ArticleId IdType="pubmed">32987855</ArticleId></ArticleIdList></Reference><Reference><Citation>Regis G., Pensa S., Boselli D., Novelli F., Poli V. Ups and downs: The STAT1:STAT3 seesaw of Interferon and gp130 receptor signalling. Semin. Cell. Dev. Biol. 2008;19:351–359. doi: 10.1016/j.semcdb.2008.06.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.semcdb.2008.06.004</ArticleId><ArticleId IdType="pubmed">18620071</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharif M.N., Tassiulas I., Hu Y., Mecklenbräuker I., Tarakhovsky A., Ivashkiv L.B. IFN-alpha priming results in a gain of proinflammatory function by IL-10: Implications for systemic lupus erythematosus pathogenesis. J. Immunol. 2004;172:6476–6481. doi: 10.4049/jimmunol.172.10.6476.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.172.10.6476</ArticleId><ArticleId IdType="pubmed">15128840</ArticleId></ArticleIdList></Reference><Reference><Citation>Herrero C., Hu X., Li W.P., Samuels S., Sharif M.N., Kotenko S., Ivashkiv L.B. Reprogramming of IL-10 activity and signaling by IFN-gamma. J. Immunol. 2003;171:5034–5041. doi: 10.4049/jimmunol.171.10.5034.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.171.10.5034</ArticleId><ArticleId IdType="pubmed">14607900</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Q., Zhu Q., Ye Q., Wang J., Dong Q., Chen Y., Wang M., Fu Y., Wu R., Wu T. STAT3 Suppresses Cardiomyocytes Apoptosis in CVB3-Induced Myocarditis via Survivin. Front. Pharmacol. 2020;11:613883. doi: 10.3389/fphar.2020.613883.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2020.613883</ArticleId><ArticleId IdType="pmc">PMC7919905</ArticleId><ArticleId IdType="pubmed">33658937</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho H.H., Ivashkiv L.B. Role of STAT3 in type I interferon responses. Negative regulation of STAT1-dependent inflammatory gene activation. J. Biol. Chem. 2006;281:14111–14118. doi: 10.1074/jbc.M511797200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M511797200</ArticleId><ArticleId IdType="pubmed">16571725</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsai M.H., Pai L.M., Lee C.K. Fine-Tuning of Type I Interferon Response by STAT3. Front. Immunol. 2019;10:448. doi: 10.3389/fimmu.2019.01448.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2019.01448</ArticleId><ArticleId IdType="pmc">PMC6606715</ArticleId><ArticleId IdType="pubmed">31293595</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang W.B., Levy D.E., Lee C.K. STAT3 negatively regulates type I IFN-mediated antiviral response. J. Immunol. 2011;187:2578–2585. doi: 10.4049/jimmunol.1004128.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1004128</ArticleId><ArticleId IdType="pubmed">21810606</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H., Yuan M., Wang S., Zhang L., Zhang R., Zou X., Wang X., Chen D., Wu Z. STAT3 Regulates the Type I IFN-Mediated Antiviral Response by Interfering with the Nuclear Entry of STAT1. Int. J. Mol. Sci. 2019;20:4870. doi: 10.3390/ijms20194870.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms20194870</ArticleId><ArticleId IdType="pmc">PMC6801597</ArticleId><ArticleId IdType="pubmed">31575039</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao Y., Zhao H., Wang P., Wang J., Zou L. The roles of SOCS3 and STAT3 in bacterial infection and inflammatory diseases. Scand. J. Immunol. 2018;88:e12727. doi: 10.1111/sji.12727.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/sji.12727</ArticleId><ArticleId IdType="pubmed">30341772</ArticleId></ArticleIdList></Reference><Reference><Citation>Carow B., Rottenberg M.E. SOCS3, a Major Regulator of Infection and Inflammation. Front. Immunol. 2014;5:58. doi: 10.3389/fimmu.2014.00058.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2014.00058</ArticleId><ArticleId IdType="pmc">PMC3928676</ArticleId><ArticleId IdType="pubmed">24600449</ArticleId></ArticleIdList></Reference><Reference><Citation>Weber M., Sediri H., Felgenhauer U., Binzen I., Bänfer S., Jacob R., Brunotte L., García-Sastre A., Schmid-Burgk J.L., Schmidt T., et al. Influenza virus adaptation PB2-627K modulates nucleocapsid inhibition by the pathogen sensor RIG-I. Cell Host Microbe. 2015;17:309–319. doi: 10.1016/j.chom.2015.01.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2015.01.005</ArticleId><ArticleId IdType="pmc">PMC4359673</ArticleId><ArticleId IdType="pubmed">25704008</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S., Dai T., Qin Z., Pan T., Chu F., Lou L., Zhang L., Yang B., Huang H., Lu H., et al. Targeting liquid-liquid phase separation of SARS-CoV-2 nucleocapsid protein promotes innate antiviral immunity by elevating MAVS activity. Nat. Cell Biol. 2021;23:718–732. doi: 10.1038/s41556-021-00710-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41556-021-00710-0</ArticleId><ArticleId IdType="pubmed">34239064</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu H., Zheng C. The Race between Host Antiviral Innate Immunity and the Immune Evasion Strategies of Herpes Simplex Virus 1. Microbiol. Mol. Biol. Rev. 2020;84:e00099-20. doi: 10.1128/MMBR.00099-20.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MMBR.00099-20</ArticleId><ArticleId IdType="pmc">PMC7528619</ArticleId><ArticleId IdType="pubmed">32998978</ArticleId></ArticleIdList></Reference><Reference><Citation>Luthra P., Ramanan P., Mire C.E., Weisend C., Tsuda Y., Yen B., Liu G., Leung D.W., Geisbert T.W., Ebihara H., et al. Mutual antagonism between the Ebola virus VP35 protein and the RIG-I activator PACT determines infection outcome. Cell Host Microbe. 2013;14:74–84. doi: 10.1016/j.chom.2013.06.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2013.06.010</ArticleId><ArticleId IdType="pmc">PMC3875338</ArticleId><ArticleId IdType="pubmed">23870315</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang M.Q., Jia X., Cheng C.Q., Wang Y., Li Y.Y., Kong L.D., Li Q.Q., Xie F., Yu Y.L., He Y.T., et al. Capsaicin functions as a selective degrader of STAT3 to enhance host resistance to viral infection. Acta Pharmacol. Sin. 2023;44:2253–2264. doi: 10.1038/s41401-023-01111-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41401-023-01111-9</ArticleId><ArticleId IdType="pmc">PMC10618195</ArticleId><ArticleId IdType="pubmed">37311796</ArticleId></ArticleIdList></Reference><Reference><Citation>Mukherjee A., Morosky S.A., Delorme-Axford E., Dybdahl-Sissoko N., Oberste M.S., Wang T., Coyne C.B. The coxsackievirus B 3C protease cleaves MAVS and TRIF to attenuate host type I interferon and apoptotic signaling. PLoS Pathog. 2017;7:e1001311</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3059221</ArticleId><ArticleId IdType="pubmed">21436888</ArticleId></ArticleIdList></Reference><Reference><Citation>Andrews D.D.T., Vlok M., Akbari Bani D., Hay B.N., Mohamud Y., Foster L.J., Luo H., Overall C.M., Jan E. Cleavage of 14-3-3ε by the enteroviral 3C protease dampens RIG-I-mediated antiviral signaling. J. Virol. 2023;97:e0060423. doi: 10.1128/jvi.00604-23.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.00604-23</ArticleId><ArticleId IdType="pmc">PMC10506458</ArticleId><ArticleId IdType="pubmed">37555661</ArticleId></ArticleIdList></Reference><Reference><Citation>Tolomeo M., Cavalli A., Cascio A. STAT1 and Its Crucial Role in the Control of Viral Infections. Int. J. Mol. Sci. 2022;23:4095. doi: 10.3390/ijms23084095.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23084095</ArticleId><ArticleId IdType="pmc">PMC9028532</ArticleId><ArticleId IdType="pubmed">35456913</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Y., Ma L., Zhuang Z., Cai S., Zhao Z., Zhou L., Zhang J., Wang P.H., Zhao J., Cui J. Main protease of SARS-CoV-2 serves as a bifunctional molecule in restricting type I interferon antiviral signaling. Signal Transduct. Target. Ther. 2020;5:221. doi: 10.1038/s41392-020-00332-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-020-00332-2</ArticleId><ArticleId IdType="pmc">PMC7537955</ArticleId><ArticleId IdType="pubmed">33024073</ArticleId></ArticleIdList></Reference><Reference><Citation>Lan K.H., Lan K.L., Lee W.P., Sheu M.L., Chen M.Y., Lee Y.L., Yen S.H., Chang F.Y., Lee S.D. HCV NS5A inhibits interferon-alpha signaling through suppression of STAT1 phosphorylation in hepatocyte-derived cell lines. J. Hepatol. 2007;46:59–67. doi: 10.1016/j.jhep.2006.11.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jhep.2006.11.013</ArticleId><ArticleId IdType="pubmed">17275127</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun M., Lin Q., Wang C., Xing J., Yan K., Liu Z., Jin Y., Cardona C.J., Xing Z. Enterovirus A71 2B Inhibits Interferon-Activated JAK/STAT Signaling by Inducing Caspase-3-Dependent Karyopherin-α1 Degradation. Front. Microbiol. 2021;12:762869. doi: 10.3389/fmicb.2021.762869.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2021.762869</ArticleId><ArticleId IdType="pmc">PMC8725996</ArticleId><ArticleId IdType="pubmed">34992585</ArticleId></ArticleIdList></Reference><Reference><Citation>Hillmer E.J., Zhang H., Li H.S., Watowich S.S. STAT3 signaling in immunity. Cytokine Growth Factor Rev. 2016;31:1–15. doi: 10.1016/j.cytogfr.2016.05.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cytogfr.2016.05.001</ArticleId><ArticleId IdType="pmc">PMC5050093</ArticleId><ArticleId IdType="pubmed">27185365</ArticleId></ArticleIdList></Reference><Reference><Citation>Guanizo A.C., Fernando C.D., Garama D.J., Gough D.J. STAT3: A multifaceted oncoprotein. Growth Factors. 2018;36:1–14. doi: 10.1080/08977194.2018.1473393.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/08977194.2018.1473393</ArticleId><ArticleId IdType="pubmed">29873274</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuchipudi S.V. The Complex Role of STAT3 in Viral Infections. J. Immunol. Res. 2015;2015:272359. doi: 10.1155/2015/272359.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2015/272359</ArticleId><ArticleId IdType="pmc">PMC4496485</ArticleId><ArticleId IdType="pubmed">26199948</ArticleId></ArticleIdList></Reference><Reference><Citation>Jafarzadeh A., Nemati M., Jafarzadeh S. Contribution of STAT3 to the pathogenesis of COVID-19. Microb. Pathog. 2021;154:104836. doi: 10.1016/j.micpath.2021.104836.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.micpath.2021.104836</ArticleId><ArticleId IdType="pmc">PMC7937040</ArticleId><ArticleId IdType="pubmed">33691172</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsia H.C., Stopford C.M., Zhang Z., Damania B., Baldwin A.S. Signal transducer and activator of transcription 3 (Stat3) regulates host defense and protects mice against herpes simplex virus-1 (HSV-1) infection. J. Leukoc. Biol. 2017;101:1053–1064. doi: 10.1189/jlb.4A1016-199RR.</Citation><ArticleIdList><ArticleId IdType="doi">10.1189/jlb.4A1016-199RR</ArticleId><ArticleId IdType="pmc">PMC5346178</ArticleId><ArticleId IdType="pubmed">27965384</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang Z., Wang Y., Bian L., Liu Q., Long J.E. Enterovirus 71 antagonizes the antiviral activity of host STAT3 and IL-6R with partial dependence on virus-induced miR-124. J. Gen. Virol. 2017;98:3008–3025. doi: 10.1099/jgv.0.000967.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/jgv.0.000967</ArticleId><ArticleId IdType="pubmed">29120300</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahony R., Gargan S., Roberts K.L. A novel anti-viral role for STAT3 in IFN-α signalling responses. Cell Mol. Life Sci. 2017;74:1755–1764. doi: 10.1007/s00018-016-2435-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-016-2435-3</ArticleId><ArticleId IdType="pmc">PMC11107673</ArticleId><ArticleId IdType="pubmed">27988795</ArticleId></ArticleIdList></Reference><Reference><Citation>Gan C.J., Li W.F., Li C.N., Li L.L., Zhou W.Y., Peng X.M. EGF receptor inhibitors comprehensively suppress hepatitis B virus by downregulation of STAT3 phosphorylation. Biochem. Biophys. Rep. 2020;22:100763. doi: 10.1016/j.bbrep.2020.100763.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrep.2020.100763</ArticleId><ArticleId IdType="pmc">PMC7170955</ArticleId><ArticleId IdType="pubmed">32322693</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J., Wu Y., Wang Y., Liu P., Liu K., Sun J., Zhang P., Wang X., Liu X., Xu X. Influenza A virus infection activates STAT3 to enhance SREBP2 expression, cholesterol biosynthesis, and virus replication. iScience. 2024;27:110424. doi: 10.1016/j.isci.2024.110424.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.isci.2024.110424</ArticleId><ArticleId IdType="pmc">PMC11301072</ArticleId><ArticleId IdType="pubmed">39108727</ArticleId></ArticleIdList></Reference><Reference><Citation>Sen N., Che X., Rajamani J., Zerboni L., Sung P., Ptacek J., Arvin A.M. Signal transducer and activator of transcription 3 (STAT3) and survivin induction by varicella-zoster virus promote replication and skin pathogenesis. Proc. Natl. Acad. Sci. USA. 2012;109:600–6055. doi: 10.1073/pnas.1114232109.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1114232109</ArticleId><ArticleId IdType="pmc">PMC3258638</ArticleId><ArticleId IdType="pubmed">22190485</ArticleId></ArticleIdList></Reference><Reference><Citation>Reitsma J.M., Sato H., Nevels M., Terhune S.S., Paulus C. Human cytomegalovirus IE1 protein disrupts interleukin-6 signaling by sequestering STAT3 in the nucleus. J. Virol. 2013;87:10763–10776. doi: 10.1128/JVI.01197-13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01197-13</ArticleId><ArticleId IdType="pmc">PMC3807375</ArticleId><ArticleId IdType="pubmed">23903834</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao Q., Yang Y., Luo Y., Chen X., Gong T., Wu D., Feng Y., Zheng X., Wang H., Zhang G., et al. African Swine Fever Virus Envelope Glycoprotein CD2v Interacts with Host CSF2RA to Regulate the JAK2-STAT3 Pathway and Inhibit Apoptosis to Facilitate Virus Replication. J. Virol. 2023;97:e0188922. doi: 10.1128/jvi.01889-22.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.01889-22</ArticleId><ArticleId IdType="pmc">PMC10134862</ArticleId><ArticleId IdType="pubmed">37022174</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsuyama T., Kubli S.P., Yoshinaga S.K., Pfeffer K., Mak T.W. An aberrant STAT pathway is central to COVID-19. Cell Death Differ. 2020;27:3209–3225. doi: 10.1038/s41418-020-00633-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41418-020-00633-7</ArticleId><ArticleId IdType="pmc">PMC7545020</ArticleId><ArticleId IdType="pubmed">33037393</ArticleId></ArticleIdList></Reference><Reference><Citation>Lindner D., Hilbrandt M., Marggraf K., Becher P.M., Hilfiker-Kleiner D., Klingel K., Pauschinger M., Schultheiss H.P., Tschöpe, Westermann D. Protective Function of STAT3 in CVB3-Induced Myocarditis. Cardiol. Res. Pract. 2012;2012:437623. doi: 10.1155/2012/437623.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2012/437623</ArticleId><ArticleId IdType="pmc">PMC3366200</ArticleId><ArticleId IdType="pubmed">22675647</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsai M.H., Lee C.K. STAT3 Cooperates With Phospholipid Scramblase 2 to Suppress Type I Interferon Response. Front. Immunol. 2018;9:1886. doi: 10.3389/fimmu.2018.01886.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.01886</ArticleId><ArticleId IdType="pmc">PMC6104169</ArticleId><ArticleId IdType="pubmed">30158934</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang P., Hou J., Lin L., Wang C., Liu X., Li D., Ma F., Wang Z., Cao X. Inducible microRNA-155 feedback promotes type I IFN signaling in antiviral innate immunity by targeting suppressor of cytokine signaling 1. J. Immunol. 2010;185:6226–6233. doi: 10.4049/jimmunol.1000491.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1000491</ArticleId><ArticleId IdType="pubmed">20937844</ArticleId></ArticleIdList></Reference><Reference><Citation>Pauli E.K., Schmolke M., Wolff T., Viemann D., Roth J., Bode J.G., Ludwig S. Influenza A virus inhibits type I IFN signaling via NF-kappaB-dependent induction of SOCS-3 expression. PLoS Pathog. 2008;4:e1000196. doi: 10.1371/journal.ppat.1000196.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1000196</ArticleId><ArticleId IdType="pmc">PMC2572141</ArticleId><ArticleId IdType="pubmed">18989459</ArticleId></ArticleIdList></Reference><Reference><Citation>Lesina M., Kurkowski M.U., Ludes K., Rose-John S., Treiber M., Klöppel G., Yoshimura A., Reindl W., Sipos B., Akira S., et al. Stat3/Socs3 activation by IL-6 transsignaling promotes progression of pancreatic intraepithelial neoplasia and development of pancreatic cancer. Cancer Cell. 2011;19:456–469. doi: 10.1016/j.ccr.2011.03.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ccr.2011.03.009</ArticleId><ArticleId IdType="pubmed">21481788</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>